Detailed functional characterization of glycosylated and nonglycosylated variants of malaria vaccine candidatePfAMA1 produced inNicotiana benthamianaand analysis of growth inhibitory responses in rabbits

Commercial Aspects of Pharmaceutical Protein Production in Plants

(2013) Rainer Fischer et al.   CURRENT PHARMACEUTICAL DESIGN

Plant-Based Production of Recombinant Plasmodium Surface Protein Pf38 and Evaluation of its Potential as a Vaccine Candidate

(2013) Tatjana Feller et al.   PLoS One

Rapid and Scalable Plant-based Production of a Cholera Toxin B Subunit Variant to Aid in Mass Vaccination against Cholera Outbreaks

(2013) Krystal Teasley Hamorsky et al.   PLoS Neglected Tropical Diseases

Glycan Masking of Plasmodium vivax Duffy Binding Protein for Probing Protein Binding Function and Vaccine Development

(2013) Sowmya Sampath et al.   PLoS Pathogens

Glycan profiles of the 27 N-glycosylation sites of the HIV envelope protein CN54gp140

(2012) Martin Pabst et al.   BIOLOGICAL CHEMISTRY

Overview of Plant-Made Vaccine Antigens against Malaria

(2012) Marina Clemente et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

Plant-derived vaccines

(2012) Mohammad Tahir Waheed et al.   Human Vaccines & Immunotherapeutics

Structural and Functional Insights into the Malaria Parasite Moving Junction Complex

(2012) Brigitte Vulliez-Le Normand et al.   PLoS Pathogens

Enhancing Blockade of Plasmodium falciparum Erythrocyte Invasion: Assessing Combinations of Antibodies against PfRH5 and Other Merozoite Antigens

(2012) Andrew R. Williams et al.   PLoS Pathogens

Affinity purification of a framework 1 engineered mouse/human chimeric IgA2 antibody from tobacco

(2011) A. Boes et al.   BIOTECHNOLOGY AND BIOENGINEERING

A Plant-Produced Pfs230 Vaccine Candidate Blocks Transmission of Plasmodium falciparum

(2011) Christine E. Farrance et al.   Clinical and Vaccine Immunology

Antibodies to plant-producedPlasmodium falciparumsexual stage protein Pfs25 exhibit transmission blocking activity

(2011) Christine E. Farrance et al.   Human vaccines & immunotherapeutics

Clinical development of plant-produced recombinant pharmaceuticals: Vaccines, antibodies and beyond

(2011) Vidadi Yusibov et al.   Human vaccines & immunotherapeutics

First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children

(2011)   NEW ENGLAND JOURNAL OF MEDICINE

Plant-made vaccines for humans and animals

(2010) Edward P. Rybicki   PLANT BIOTECHNOLOGY JOURNAL

Adenovectors induce functional antibodies capable of potent inhibition of blood stage malaria parasite growth

(2010) Joseph T. Bruder et al.   VACCINE

Anti-Apical-Membrane-Antigen-1 Antibody Is More Effective than Anti-42-Kilodalton-Merozoite-Surface-Protein-1 Antibody in Inhibiting Plasmodium falciparum Growth, as Determined by the In Vitro Growth Inhibition Assay

(2009) K. Miura et al.   Clinical and Vaccine Immunology

A Diversity-Covering Approach to Immunization with Plasmodium falciparum Apical Membrane Antigen 1 Induces Broader Allelic Recognition and Growth Inhibition Responses in Rabbits

(2008) E. J. Remarque et al.   INFECTION AND IMMUNITY

Safety and Immunogenicity of an AMA-1 Malaria Vaccine in Malian Adults: Results of a Phase 1 Randomized Controlled Trial

(2008) Mahamadou A. Thera et al.   PLoS One

Safety and Immunogenicity of a Recombinant Plasmodium falciparum AMA1 Malaria Vaccine Adjuvanted with Alhydrogel™, Montanide ISA 720 or AS02

(2008) Meta Roestenberg et al.   PLoS One

Apical membrane antigen 1: a malaria vaccine candidate in review

(2008) Edmond J. Remarque et al.   TRENDS IN PARASITOLOGY

Hot, sweet and sticky: the glycobiology of Plasmodium falciparum

(2008) Mark von Itzstein et al.   TRENDS IN PARASITOLOGY

Production, quality control, stability and pharmacotoxicity of cGMP-produced Plasmodium falciparum AMA1 FVO strain ectodomain expressed in Pichia pastoris

(2008) Bart W. Faber et al.   VACCINE